Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001970149 | SCV002235822 | pathogenic | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu511Valfs*25) in the GFM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GFM1 are known to be pathogenic (PMID: 16632485, 17160893). This variant is present in population databases (rs768112611, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with GFM1-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252739 | SCV002523615 | likely pathogenic | See cases | 2020-03-13 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PM2 |
Baylor Genetics | RCV003471167 | SCV004199293 | likely pathogenic | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 | 2023-10-11 | criteria provided, single submitter | clinical testing |